In obesity, the circulating plasma levels of HMW and LMW adiponectin are reduced, and this altered adiponectin oligomeric profile has been suggested to be a reliable clinical indicator of metabolic disorders (33). This evidence concerns the gene ADIPOQ and metabolic disease.